2 Results for "

recombinant human erythropoietin

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "recombinant human erythropoietin" in MCE Product Catalog:

Cat. No.: HY-174428
Target:  

PROTACs JAK STAT Apoptosis

Research Areas:  

Cancer

PROTAC JAK2 degrader-1 is a JAK2 PROTAC degrader, with a DC50 of 27.35 nM. PROTAC JAK2 degrader-1 induces JAK2 degradation via the ubiquitin-proteasome pathway. PROTAC JAK2 degrader-1 inhibits the JAK2-STAT signaling pathway. PROTAC JAK2 degrader-1 induces G2/M phase arrest and apoptosis in cancer cells. PROTAC JAK2 degrader-1 exhibits antiproliferative activity against cancer cells. PROTAC JAK2 degrader-1 inhibits recombinant human erythropoietin (rhEPO)-mediated polycythemia and splenomegaly in mice. PROTAC JAK2 degrader-1 can be used for research on myeloproliferative neoplasms, including polycythemia vera .
loading...
    loading...
Cat. No.: HY-108864
CAS No.: 113427-24-0
Synonyms: Epogen

Research Areas:  

Cardiovascular Disease Cancer

Epoetin alfa (Epogen) is a recombinant human erythropoietin whose amino acid sequence and biological activity are identical to those of endogenous erythropoietin (EPO). Epoetin alfa is a direct agonist of the EPO receptor (EPOR) on the surface of erythroid progenitor cells, and promotes the production and maturation of red blood cells. Epoetin alfa can be used for research on myelodysplastic syndrome-related anemia and hematological malignancies .
loading...
    loading...